Related Experiment Videos

[Methicillin-resistant Staphylococcus aureus nosocomial infections in ICU: risk factors, morbidity and cost]

D Lepelletier1, S Ferréol, D Villers

  • 1Laboratoire de bactériologie-virologie, hygiène hospitalière, hôpital Laënnec, boulevard Jean-Monod, CHU de Nantes, 44100 Nantes cedex 01, France. didier.lepelletier@chu-nantes.fr

Pathologie-Biologie
|October 7, 2004
PubMed
Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) infections are associated with increased length of stay and higher antimicrobial treatment costs compared to methicillin-susceptible Staphylococcus aureus (MSSA) infections. However, MRSA did not significantly impact mortality rates in this study.

Area of Science:

  • Infectious Diseases
  • Medical Microbiology
  • Healthcare Epidemiology

Context:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant challenge in healthcare settings.
  • Nosocomial infections caused by MRSA and methicillin-susceptible Staphylococcus aureus (MSSA) require comparative analysis.
  • Understanding risk factors, morbidity, and costs associated with MRSA and MSSA is crucial for effective management.

Purpose:

  • To evaluate and compare the risk factors, morbidity, and economic costs of nosocomial infections caused by MRSA versus MSSA.
  • To identify differences in patient demographics and clinical outcomes between MRSA and MSSA infections.
  • To quantify the additional financial burden imposed by MRSA infections.

Summary:

  • A case-control study compared 24 MRSA infections with 64 MSSA infections in a medical intensive care unit.
  • MRSA patients were older, had longer hospital stays, and later onset of infection compared to MSSA patients.
  • No significant differences were found in mortality or severity scores (Omega index, acute simplify index) between MRSA and MSSA groups.

Impact:

  • MRSA infections incur substantial extra costs, primarily from antimicrobial treatments and extended hospital stays.
  • While MRSA does not increase mortality, it significantly elevates healthcare expenditures.
  • These findings highlight the economic impact of antibiotic resistance and the need for targeted infection control strategies.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...